Approvals/CIMA-AEMPS/MOXIFLOXACINO REIWA HEALTHCARE 400 MG/250 ML SOLUCION PARA PERFUSION EFG

Approved

STANDARD

MOXIFLOXACINO REIWA HEALTHCARE 400 MG/250 ML SOLUCION PARA PERFUSION EFG

Reiwa Healthcare S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: ce5a1df3e1acdc02
Drug Cima Aemps Name: MOXIFLOXACINO REIWA HEALTHCARE 400 MG/250 ML SOLUCION PARA PERFUSION EFG
Register Number: 88999
Holder Company Name: Reiwa Healthcare S.L.
Marketing Company Name: Reiwa Healthcare S.L.
Authorization Date: 2023-07-31
Dosage Form: SOLUCIÓN PARA PERFUSIÓN
Dose: 400 MG/250 ML
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Reiwa Healthcare S.L.

MOXIFLOXACINO HIDROCLORURO

436,37 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 31, 2023

Approval ID

ce5a1df3e1acdc02

Type

Standard